---

**UNITED STATESSECURITIES AND EXCHANGE COMMISSION** Washington, D.C. 20549

FORM 10-QSB

**x****** Quarterly
  Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
  For the quarterly period ended November 30, 2003

** ̈******Transition
  Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934
  For the transition period _______________ to __________________

Commission File Number 333-86706

CROWN MEDICAL SYSTEMS, INC.
  (Exact name of small Business Issuer as specified in its charter)

|Nevada                                          | 98-0375957                       
|----------------------------------------------- | ---------------------------------
|(State or other jurisdiction of                 | (IRS Employer Identification No.)
|incorporation or organization)                  |                                  
|                                                |                                  
|Box 18, Suite 323-595 Howe Street               |                                  
|Vancouver, British Columbia, Canada             | V6C 2T5                          
|(Address of principal executive offices)        | (Postal or Zip Code)             
|                                                |                                  
|Issuers telephone number, including area code: | 604-682-8468                     

Link Media Publishing Ltd. 
  (Former name, former address and former fiscal year, if changed since last report)

Check whether the issuer (1) filed all reports required to
  be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
  the preceding 12 months (or for such shorter period that the issuer was required
  to file such reports), and (2) has been subject to such filing requirements
  for the past 90 days **x******
  Yes  ** ̈******
  No

State the number of shares outstanding of each of the issuers
  classes of common stock, as of the latest practicable date: 31,951,835 Shares
  of $0.001 par value Common Stock outstanding as of November 30, 2003.

---

PART 1  FINANCIAL INFORMATION

Item 1. Financial StatementsThe accompanying unaudited financial statements have been prepared in accordance
  with the instructions to Form 10-QSB and Item 310 (b) of Regulation S-B, and,
  therefore, do not include all information and footnotes necessary for a complete
  presentation of financial position, results of operations, cash flows, and stockholders
  equity in conformity with generally accepted accounting principles. In the opinion
  of management, all adjustments considered necessary for a fair presentation
  of the results of operations and financial position have been included and all
  such adjustments are of a normal recurring nature. Operating results for the
  nine months ended November 30, 2003 are not necessarily indicative of the results
  that can be expected for the year ending February 29, 2004.

---

CROWN MEDICAL SYSTEMS, INC.
  (Formally Link Media Publishing Ltd.)

(a development stage company)

INTERIM CONSOLIDATED FINANCIAL STATEMENTS

NOVEMBER 30, 2003

(Unaudited)





CONSOLIDATED BALANCE SHEETS

INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS

INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS

---

CROWN MEDICAL SYSTEMS, INC.
  (Formally Link Media Publishing Ltd.) 
  (a development stage company) 
  CONSOLIDATED BALANCE SHEETS

|                                                                     |   | November 30, |   |   | February 28, |  
|-------------------------------------------------------------------- | - | ------------ | - | - | ------------ | -
|                                                                     |   | 2003         |   |   | 2003         |  
|                                                                     |   | (Unaudited)  |   |   |              |  
|                                                                     |   |              |   |   |              |  
|ASSETS                                                               |  
|                                                                     |   |              |   |   |              |  
|CURRENT ASSETS                                                       |   |              |   |   |              |  
|Cash                                                                 | $ | 665          |   | $ | 3,372        |  
|Accounts receivable                                                  |   | 3,870        |   |   | 5,210        |  
|Other
      receivables                                              |   | -            |   |   | 723          |  
|                                                                     |   |              |   |   |              |  
|                                                                     |   | 4,535        |   |   | 9,305        |  
|                                                                     |   |              |   |   |              |  
|EQUIPMENT                                                            |   | 590          |   |   | 695          |  
|                                                                     |   |              |   |   |              |  
|                                                                     | $ | 5,125        |   | $ | 10,000       |  
|                                                                     |   |              |   |   |              |  
|LIABILITIES AND STOCKHOLDERS EQUITY
      (CAPITAL DEFICIENCY)      |  
|                                                                     |   |              |   |   |              |  
|CURRENT LIABILITIES                                                  |   |              |   |   |              |  
|Accounts payable                                                     | $ | 12,990       |   | $ | 6,782        |  
|Loans
      payable                                                  |   | 4,000        |   |   | -            |  
|                                                                     |   |              |   |   |              |  
|                                                                     |   | 16,990       |   |   | 6,782        |  
|                                                                     |   |              |   |   |              |  
|GOING CONCERN CONTINGENCIES(Note 1)                                  |   |              |   |   |              |  
|                                                                     |   |              |   |   |              |  
|STOCKHOLDERS EQUITY (CAPITAL DEFICIENCY)                            |   |              |   |   |              |  
|Capital stock (Note 5)                                               |   |              |   |   |              |  
|Common
      stock, $0.001 par value, 70,000,000 shares authorized   |   |              |   |   |              |  
|Preferred
      stock, $0.001 par value, 5,000,000 shares authorized |   |              |   |   |              |  
|31,951,835
      post-split common shares issued and outstanding     |   |              |   |   |              |  
|(February
      28, 2002 - 6,100,000 shares)                         |   | 6,390        |   |   | 6,390        |  
|Additional
      paid-in capital                                     |   | 86,820       |   |   | 86,820       |  
|Other comprehensive income
      (loss)                              |   | (1,026       | ) |   | (1,165       | )
|Deficit
      accumulated during the development stage               |   | (104,049     | ) |   | (88,827      | )
|                                                                     |   |              |   |   |              |  
|                                                                     |   | (11,865      | ) |   | 3,218        |  
|                                                                     |   |              |   |   |              |  
|                                                                     | $ | 5,125        |   | $ | 10,000       |  

The accompanying notes are an integral part of these interim
  consolidated financial statements

---

CROWN MEDICAL SYSTEMS, INC.
  (Formally Link Media Publishing Ltd.) 
  (a development stage company) INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

|                                    |   | Three month  |   |   | Nine month   |   |   | Three month  |   |   | Nine month   |  
|----------------------------------- | - | ------------ | - | - | ------------ | - | - | ------------ | - | - | ------------ | -
|                                    |   | period ended |   |   | period ended |   |   | period ended |   |   | period ended |  
|                                    |   | November30,  |   |   | November 30, |   |   | November 30, |   |   | November 30, |  
|                                    |   | 2002         |   |   | 2002         |   |   | 2003         |   |   | 2003         |  
|                                    |   |              |   |   |              |   |   |              |   |   |              |  
|REVENUE                             | $ | -            |   | $ | 16,470       |   | $ | 946          |   | $ | 946          |  
|                                    |   |              |   |   |              |   |   |              |   |   |              |  
|GENERAL AND ADMINISTRATIVE EXPENSES |   |              |   |   |              |   |   |              |   |   |              |  
|Bad debts                           |   | 10,680       |   |   | 10,680       |   |   | 354          |   |   | 647          |  
|Commissions                         |   | -            |   |   | 558          |   |   | -            |   |   | -            |  
|Consulting fees                     |   | 886          |   |   | 6,386        |   |   | -            |   |   | -            |  
|Office and general                  |   | 3,316        |   |   | 13,390       |   |   | 1,568        |   |   | 6,997        |  
|Printing, design and distribution   |   | 381          |   |   | 4,942        |   |   | -            |   |   | -            |  
|Professional fees                   |   | 6,110        |   |   | 18,647       |   |   | 1,962        |   |   | 8,524        |  
|Travel
      and promotion          |   | 22           |   |   | 1,288        |   |   | -            |   |   | -            |  
|                                    |   |              |   |   |              |   |   |              |   |   |              |  
|                                    |   | 21,395       |   |   | 55,891       |   |   | 3,884        |   |   | 16,168       |  
|                                    |   |              |   |   |              |   |   |              |   |   |              |  
|NET LOSS FOR THE PERIOD             | $ | (21,395      | ) | $ | (39,421      | ) | $ | (2,938       | ) | $ | (15,222      | )
|                                    |   |              |   |   |              |   |   |              |   |   |              |  
|BASIC NET LOSS PER SHARE            | $ | (0.00        | ) | $ | (0.00        | ) | $ | (0.00        | ) | $ | (0.00        | )
|                                    |   |              |   |   |              |   |   |              |   |   |              |  
|WEIGHTED AVERAGE COMMON SHARES      |   |              |   |   |              |   |   |              |   |   |              |  
|OUTSTANDING                         |   | 31,951,835   |   |   | 31,951,835   |   | $ | 31,951,835   |   |   | 31,951,835   |  

The accompanying notes are an integral part of these interim
  consolidated financial statements

---

CROWN MEDICAL SYSTEMS, INC.
  (Formally Link Media Publishing Ltd.) 
  (a development stage company) INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

|                                                             |   | Nine month   |   |   | Nine month   |  
|------------------------------------------------------------ | - | ------------ | - | - | ------------ | -
|                                                             |   | period ended |   |   | period ended |  
|                                                             |   | November 30, |   |   | November 30, |  
|                                                             |   | 2002         |   |   | 2003         |  
|                                                             |   |              |   |   |              |  
|CASH FLOWS FROM OPERATING ACTIVITIES                         |   |              |   |   |              |  
|Net loss for the period                                      | $ | (39,421      | ) | $ | (15,222      | )
|Adjusted for item not
      involving cash:                  |   |              |   |   |              |  
|depreciation                                                 |   | -            |   |   | 105          |  
|                                                             |   |              |   |   |              |  
|                                                             |   | (39,421      | ) |   | (15,117      | )
|Net
      changes in non-cash working capital items          |   | (12,851      | ) |   | 12,271       |  
|                                                             |   |              |   |   |              |  
|NET CASH FLOWS USED IN OPERATING ACTIVITIES                  |   | (52,272      | ) |   | (2,846       | )
|                                                             |   |              |   |   |              |  
|CASH FLOWS FROM INVESTING ACTIVITIES                         |   |              |   |   |              |  
|Acquisition
      of equipment                               |   | (772         | ) |   | -            |  
|                                                             |   |              |   |   |              |  
|NET CASH FLOWS USED IN INVESTING ACTIVITIES                  |   | (772         | ) |   | -            |  
|                                                             |   |              |   |   |              |  
|CASH FLOWS FROM FINANCING ACTIVITIES                         |   |              |   |   |              |  
|Proceeds from common share
      subscriptions and issuances |   | 15,810       |   |   | -            |  
|Net
      repayments to related party                        |   | (10,661      | ) |   | -            |  
|                                                             |   |              |   |   |              |  
|NET CASH FLOWS FROM FINANCING ACTIVITIES                     |   | 5,149        |   |   | -            |  
|                                                             |   |              |   |   |              |  
|EFFECT OF FOREIGN EXCHANGE RATE CHANGES ON CASH              |   | (1,438       | ) |   | 139          |  
|                                                             |   |              |   |   |              |  
|INCREASE (DECREASE) IN CASH                                  |   | (49,333      | ) |   | (2,707       | )
|                                                             |   |              |   |   |              |  
|CASH, BEGINNING OF PERIOD                                    |   | 54,711       |   |   | 3,372        |  
|                                                             |   |              |   |   |              |  
|CASH, END OF PERIOD                                          | $ | 5,378        |   | $ | 665          |  

The accompanying notes are an integral part of these interim
  consolidated financial statements

---

|CROWN MEDICAL SYSTEMS, INC.
      (Formally Link Media Publishing Ltd.) 
      (a development stage company) NOTES TO INTERIM CONSOLIDATED
      FINANCIAL STATEMENTS NOVEMBER 30, 2003
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|(Unaudited)                                                                                                                                                                            

NOTE 1  NATURE OF OPERATIONS AND BASIS OF PRESENTATION

The Company, through an agreement dated February 15, 2002 and completed on February 22, 2002, acquired 100% of the issued and outstanding shares of Business to Business Publishing Inc. (B2B), a private British Columbia, Canada, company
involved in the business of publishing specialized interest publications targeting particular readership in exchange for 2,600,000 shares (13,000,000 post split shares) of the Company. The Company has completed a registration statement filed with
the Securities and Exchange Commission and has listed its shares for trading on the OTC Bulletin Board in the USA.

The Company has incurred losses since inception totalling $104,049 and due to the lack of working capital ceased the operations of B2B during the fourth quarter of fiscal 2002 and accordingly, commencing March 1, 2003 the Company is considered a
development stage company as it no longer had any business operations. The ability to continue as a going concern is dependent on raising additional capital to fund future operations and ultimately to attain profitable operations. Accordingly, these
factors raise substantial doubt as to the Companys ability to continue as a going concern.

Refer to Note 7  Subsequent Events.

Unaudited Interim Financial Statements 
  The accompanying unaudited interim consolidated financial statements have been
  prepared in accordance with generally accepted accounting principles for interim
  financial information and with the instructions to Form 10-QSB of Regulation
  S-B. They do not include all information and footnotes required by generally
  accepted accounting principles for complete financial statements. However, except
  as disclosed herein, there has been no material changes in the information disclosed
  in the notes to the financial statements for the year ended February 28, 2003
  included in the Companys Annual Report on Form 10-KSB filed with the Securities
  and Exchange Commission. The interim unaudited consolidated financial statements
  should be read in conjunction with those financial statements included in the
  Form 10-KSB. In the opinion of Management, all adjustments considered necessary
  for a fair presentation, consisting solely of normal recurring adjustments,
  have been made. Operating results for the nine months ended November 30, 2003
  are not necessarily indicative of the results that may be expected for the year
  ending February 28, 2004.

NOTE 2  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Organization 
  The Company was incorporated on January 29, 2002 in the State of Nevada. The
  Companys fiscal year end is February 28 with its initial period being
  from January 29, 2002 (inception) to February 28, 2002.

Principles of Consolidation 
  The consolidated financial statements include the accounts of the Company and
  its wholly-owned subsidiary, Business to Business Publishing Inc. (B2B),
  incorporated on December 15, 2000 in British Columbia, Canada. All significant
  intercompany transactions and account balances have been eliminated.

Use of Estimates and Assumptions 
  Preparation of the Companys financial statements in conformity with generally
  accepted accounting principles requires management to make estimates and assumptions
  that affect certain reported amounts and disclosures. Accordingly, actual results
  could differ from those estimates.

Cash and Cash Equivalents 
  The Company considers all liquid investments, with an original maturity of three
  months or less when purchased, to be cash equivalents.

---

|CROWN
      MEDICAL SYSTEMS, INC.
      (Formally Link Media Publishing Ltd.) 
      (a development stage company) NOTES TO INTERIM CONSOLIDATED
      FINANCIAL STATEMENTS NOVEMBER 30, 2003
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|(Unaudited)                                                                                                                                                                                  

NOTE 2  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (contd)

Foreign Currency Translation 
  The financial statements are presented in United States dollars. In accordance
  with Statement of Financial Accounting Standards No. 52, Foreign Currency
  Translation, foreign denominated monetary assets and liabilities are translated
  to their United States dollar equivalents using foreign exchange rates, which
  prevailed at the balance sheet date. Revenue and expenses are translated at
  average rates of exchange during the year. Related translation adjustments are
  reported as a separate component of stockholders equity, whereas gains
  or losses resulting from foreign currency transactions are included in results
  of operations.

Fair Value of Financial Instruments 
  In accordance with the requirements of SFAS No. 107, the Company has determined
  the estimated fair value of financial instruments using available market information
  and appropriate valuation methodologies. The fair value of financial instruments
  classified as current assets or liabilities approximate carrying value due to
  the short-term maturity of the instruments.

Net Loss per Common Share 
  Basic earnings per share includes no dilution and is computed by dividing income
  available to common stockholders by the weighted average number of common shares
  outstanding for the period. Dilutive earnings per share reflects the potential
  dilution of securities that could share in the earnings of the Company. Because
  the Company does not have any potentially dilutive securities, the accompanying
  presentation is only of basic loss per share. Net loss per share for the period
  ended November 30, 2002 has been restated to give retroactive effect to the
  5:1 stock split in 2003.

Stock-Based Compensation 
  The Company has not adopted a stock option plan and has not granted any stock
  options. Accordingly no stock-based compensation has been recorded in any period.

Income taxes 
  The Company follows the liability method of accounting for income taxes. Under
  this method, future tax assets and liabilities are recognized for the future
  tax consequences attributable to differences between the financial statement
  carrying amounts of existing assets and liabilities and their respective tax
  balances. Future tax assets and liabilities are measured using enacted or substantially
  enacted tax rates expected to apply to the taxable income in the years in which
  those differences are expected to be recovered or settled. The effect on future
  tax assets and liabilities of a change in tax rates is recognized in income
  in the period that includes the date of enactment or substantive enactment.
  As at February 28, 2003 the Company had net operating loss carryforwards; however,
  due to the uncertainty of realization the Company has provided a full valuation
  allowance for the deferred tax assets resulting from these loss carryforwards.

Goodwill 
  In July 2001, the FASB issued Statement of Financial Accounting Standards No.
  142 (SFAS 142), Goodwill and Intangible Assets, which
  revises the accounting for purchased goodwill and intangible assets. Under SFAS
  142, goodwill and intangible assets with indefinite lives will no longer be
  amortized and will be tested for impairment annually or whenever events or circumstances
  indicate that the estimated fair value is less than the related carrying value
  as determined on a reporting unit basis. SFAS 142 is effective for fiscal years
  beginning after December 15, 2001. (Refer to Note 4)

NOTE 3  RELATED PARTY TRANSACTIONS

Upon acquisition of B2B the directors of B2B were appointed directors of the Company.

---

|CROWN
      MEDICAL SYSTEMS, INC.
      (Formally Link Media Publishing Ltd.) 
      (a development stage company) NOTES TO INTERIM CONSOLIDATED
      FINANCIAL STATEMENTS NOVEMBER 30, 2003
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|(Unaudited)                                                                                                                                                                                  

NOTE 4  ACQUISITION OF BUSINESS TO BUSINESS PUBLISHING INC.

The Company, through an agreement dated February 15, 2002 and completed on February 22, 2002, acquired 100% of the issued and outstanding shares of B2B, in exchange for 2,600,000 restricted shares of the Company. B2B was incorporated in British
Columbia on December 15, 2000 and which commenced operations on July 1, 2001.

During the fourth quarter of 2002 the Company ceased the operations of B2B due to the lack of working capital. Management is seeking new financing to fund future operations but to date has not been successful in raising required funds. Accordingly,
at the year-end February 28, 2003 the Company wrote off the carrying value of goodwill relating to B2B of $41,075. Refer to Note 7  Subsequent Events.

NOTE 5 - CAPITAL STOCK

The Companys capitalization is 70,000,000 common shares with a par value of $0.001 per share and 5,000,000 preferred shares with a par value of $0.001.

During the year ended February 28, 2003 the Company completed a private placement of 290,367 common shares at a price of $0.30 per share for total proceeds of $87,110.

On July 14, 2003, the Company completed a 5:1 stock split of its outstanding share capital in connection with the proposed acquisition of Crown Medical Systems, Inc. resulting in an increase in outstanding common shares from 6,390,367 shares to
31,951,835 shares. Refer to Note 7.

To November 30, 2003, the Company has not granted any stock options and has not recorded any stock-based compensation.

NOTE 6  INCOME TAXES

The Company and its subsidiary have net operating loss carry-forwards of approximately $104,000, which may be available to offset future taxable income. These losses will expire beginning in 2009. Due to the uncertainty of realization of these loss
carry forwards, the benefit is not reflected in the financial statements as the Company has provided a full valuation allowance for the deferred tax assets resulting from these loss carry forwards.

NOTE 7  SUBSEQUENT EVENTS

|(1) | On September 3, 2003, the Company executed an
      Agreement and Plan of Merger (the Agreement) with Crown Medical
      Systems, Inc. (Crown). This Agreement takes precedent over the
      Share Purchase Agreement executed June 20, 2003. Crown Medical is a private
      Delaware company that provides computer software, hardware and support solutions
      to the health care industry. The Agreement and Plan of Merger is subject
      to approval of the shareholders of Crown Medical Systems, Inc and a final
      closing The terms of the agreement provide inter alia for:
|--- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
|    | (a)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
|    | (b)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
|    | (c)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
|    | (d)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
|    | (e)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

---

|CROWN
      MEDICAL SYSTEMS, INC.
      (Formally Link Media Publishing Ltd.) 
      (a development stage company) NOTES TO INTERIM CONSOLIDATED
      FINANCIAL STATEMENTS NOVEMBER 30, 2003
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|(Unaudited)                                                                                                                                                                                  

|    | (f)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Preferred Shares  The Company has also agreed to issue
      5,000,000 non-voting non-participating preferred shares to Crown management,
      convertible into common shares of the Company, on a one to one basis, upon
      the booking of $10,000,000 of sales revenue in any twelve month period.                                                                                                                                                                                                                                                                                                                                                                                        
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|    | (g)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Effective December 18, 2003, the Company executed a name
      change to Crown Medical Systems, Inc. The Companys trading symbol
      was changed to CWMS for trading on the Over The Counter Bulletin Board.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|    | (h)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Options  Certain key employees and consultants of
        Crown will be granted a total of 1,500,000 options to acquire shares of
        The Companys common stock at a price of $0.75 per share for a period
        of 60 months.
      Upon completion of the transactions described above, the former shareholders
        of Crown will own approximately 65% (52% on a diluted basis) of the common
        shares of the Company. As there will be a change in control of the Company,
        the transactions will be accounted for as a reverse merger with Crown
        being treated as the accounting parent and the Company being treated as
        the accounting subsidiary.
|    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
|(2) | On January 8, 2004 the Company appointed Mr.
      William Sklar to the position of Director, President and Chief Executive
      Officer, and Mr. Paul Marshall, Brian Knight and James Sterling to the position
      of Director of the Company. The previous Board of Director members, Robert
      Hoegler, Mario Aiello and Earl Hope, have tendered their resignation from
      their positions. Mr. Mario Aiello will retain his position as secretary
      of the Company to facilitate the transition and to assist in the anticipated
      closing of the Plan of Merger.
|    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
|(3) | Effective January 12,2004 the Company executed
      an Agreement to purchase 100% interest in a proprietary Electronic Medical
      Record (EMR) software program used by medical practitioners to document
      patients encounters and to replace existing paper-based patient charts.
      The consideration to be paid to purchase the asset will be 1,500,000 shares
      of the Companys common stock and will be subject to the closing of
      the Agreement and Plan of Merger with Crown Medical (Delaware).                                                          
|    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
|(4) | Effective January 12, 2004 the Company executed
      a Corporate Communication Consulting Agreement with Crosschek Capital (Crosschek)
      of Scottsdale, Arizona whereby Crosschek will provide consulting services
      relating to the development, implementation and maintenance of an ongoing
      program to create awareness of the Companys activities in the investment
      communities. Crosschek will be compensated with a monthly retainer of $5,000
      for a period of one year.                                                                            

---

Item 2. Plan of Operation

Crown Medical Systems, Inc. ("the Company") was incorporated as Link Media Publishing Ltd. in the state of Nevada on January 29, 2002. Pursuant to an Agreement dated February 15, 2002, and completed February 22, 2002, the Company acquired all of the
issued and outstanding shares of Business-to-Business Publishing Ltd. ("B2B"), a British Columbia, Canada corporation, in consideration of 2,600,000 (13,000,000 post split) restricted shares of its common stock and by advancing B2B with $50,000 in
long-term loans carrying no interest or fixed terms of repayment. As a result of the transaction B2B has become a wholly owned subsidiary of the Company and their operations have been merged.

The Company through B2B, which has no salaried employees, was considered a start-up corporation involved in the production and distribution of industry specific and special interests wall planners. The wall planners were distributed, free of charge,
to targeted professionals or individuals who comprise the industry or interest groups for which the planners were designed and produced.

Prior to our fiscal year ended February 28, 2003, our subsidiary suspended operations due to our failure to raise sufficient working capital to fund ongoing operations and our inability to attain profitable operations. We attempted to raise
additional financing to fund and restart the publishing operations, but were not successful.

For the period ended November 30, 2003, the Company had total assets of US $5,125, including cash resources of $665, accounts receivable of $3,870 and property and equipment $590, The cash and equivalents represent the Company present source of
liquidity.

The Companys liabilities at November 30, 2003 totaled $16,990, consisting of $12,990 in accounts payables and $4,000 in loans payables.

During the quarter ended November 30, 2003 the Company had no revenues and net losses for the period of $2,938.

The Company has not realized any revenues for the period and it is presently operating at an ongoing deficit. The Companys ability to continue as an ongoing concern is dependent on its ability to generate revenues from new operation. Failing
that, the Company may need to raise additional capital, either debt or equity capital, to fund future operation and ultimately to attain profitable operation.

Pursuant to a Share Purchase Agreement dated June 20, 2003, subsequently replaced by an Agreement and Plan of Merger (the Agreement) dated September 3, 2003, the Company agreed to the following:

| | (a) | Share Split  the current and outstanding shares of
      the Company are to be split on a five for one basis. The 5:1 split took
      place on July 14, 2003.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
| | --- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| |     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
| | (b) | Disposal of B2B  as a condition precedent to the
        acquisition of Crown Medical Systems, Inc., the Company will dispose of
        its interest in B2B to two Directors of the Company in exchange for 2,600,000
        (13,000,000 post split) restricted common shares issued as consideration
        for the acquisition of the B2B.
      The Company will cancel the re-acquired shares, and the B2B nominated
        directors will resign. The Company will incur a gain of approximately
        $4,000 on the disposal of B2B.
      Subsequent to November 30, 2003 Mario Aiello, Robert Hoegler and Earl
        Hope have resigned from all their position on the Board of the Company.
        Mario Aiello will retain his position of secretary of the Company until
        the closing of the Agreement and Plan of Merger.
| |     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
| | (c) | Re Purchase of Shares  The Company will acquire for
      treasury, 2,000,000 (10,000,000 post split) restricted common shares from
      a director for nominal consideration.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
| |     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
| | (d) | Merger  each current Company shareholder will receive
      one new share for each share they held in the Company.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
| |     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
| | (e) | Acquisition of Crown Medical Systems, Inc.  the current
      Crown shareholders will receive 16,500,000 post split shares as consideration
      for the acquisition, on the basis of 0.825 new share for each one current
      Crown share of which 6,500,000 will be newly issued and 10,000,000 will
      come from the treasury shares acquired from a Director as more fully described
      in (c) above. These shares are subject to rule 144 restrictions.                                                                                                                                                                                                                                                                                                                                                                                

---

| | (f) | Preferred Shares  The Company has also agreed to issue
      5,000,000 non-voting, non-participating preferred shares to the Crown management,
      convertible into common shares of the Company, on a one for one basis, upon
      the booking of $10,000,000 of sales revenue in any twelve-month period.
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| |     |                                                                                                                                                                                                                                                                                                                
| | (g) | Options  Certain key employees and consultants of Crown
      will be granted a total of 1,500,000 options to acquire shares of the Companys
      common stock at a price of $0.75 per share for a period of 60 months.                                                                                     

The Agreement and Plan of Merger is subject to approval of the shareholders of Crown Medical Systems, Inc.

In connection with the anticipated closing the Agreement and Plan of Merger and subsequent to November 30, the present directors: Robert Hoegler, Earl Hope and Mario Aiello have resigned from the Board of the Company Mario Aiello will retain his
position as Secretary. William Sklar of Toronto, Ontario has been appointed to the positions of director, President and Chief Executive Officer; Mr Paul Marshall has been appointed to the positions of Director and Chief Financial Officer of the
Company and Messrs. Brian D. Knight and James A. Sterling, affiliates of Crown Medical (Delaware) have been appointed to the position of directors.

Effective December 18, 2003, the Company executed a name change to Crown Medical Systems, Inc. The Companys trading symbol was changed to CWMS for trading on the Over The Counter Bulletin Board.

Subsequent to November 30, 2003 the Company has executed the following agreements:

| | 1. | Acquisition Agreement to purchase 100% interest in a proprietary
      Electronic Medical Record (EMR) software program from Sonya and Dr. Mark
      Jennings. This proprietary electronic software is used by medical practitioners
      to document patients encounters and to replace existing paper-based
      patient charts. The consideration to be paid to purchase the asset will
      be 1,500,000 shares of the Companys common stock and will be subject
      to the closing of the Agreement and Plan of Merger with Crown Medical (Delaware).
| | -- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| |    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
| | 2. | Corporate Communication Consulting Agreement with Crosschek
      Capital (Crosschek) of Scottsdale, Arizona whereby Crosschek
      will provide consulting services relating to the development, implementation
      and maintenance of an ongoing program to create awareness of the Companys
      activities in the investment communities. Crosschek will be compensated
      with a monthly retainer of $5,000 for a period of one year.                                                                                                              

The Company anticipates that additional funding will be required in the form of equity financing from the sale of its common stock to finance the development of the acquired asset. There is no assurance that the Company will be able to achieve
additional sales of its common stock sufficient to fund its future development. Presently it does not have any arrangements in place for future equity financing.

The Company anticipates incurring approximately $32,800 for administrative expenses including accounting and audit costs ($9,000) legal fees ($7,000), rent and office costs ($6,000), computer costs ($1,800), telephone costs ($1,800) and general
administrative costs ($7,200) over the next 12 months.

Forward-Looking Statements

This Form 10-QSB includes -" forward-looking statements" within the meaning of the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to a
number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.

All statements other than historical facts included in this Form, including without limitation, statements under "Plan of Operation", regarding the Company's financial position, business strategy, and plans and objectives of management of the
Company for the future operations, are forward-looking statements.

Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Important factors that could cause actual results to
differ materially from the Company's expectations include, but are not limited to, market conditions, competition and the ability to successfully complete financing.

---

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

The Company is not a party to any pending legal proceeding. Management is not aware of any threatened litigation, claims or assessments.

Item 2. Changes in Securities

On July 14, 2003, the Company completed a 5:1 stock split of its outstanding share capital in connection with the proposed acquisition of Crown Medical Systems, Inc. resulting in an increase in outstanding common shares from 6,390,367 shares to
31,951,835 shares.

Item 3. Defaults Upon Senior Securities

None

Item 4. Submission of Matters to a Vote of Security Holders

None

Item 5. Other Information

None

Item 6. Exhibits and Report on Form 8-K

|31.1 | Certification of Chief Executive Officer pursuant
      to Section 302 of the Sarbanes- Oxley Act of 2002                                                     
|---- | --------------------------------------------------------------------------------------------------------------------------------------------------------------
|     |                                                                                                                                                               
|31.2 | Certification of Chief Accounting Officer pursuant
      to Section 302 of the Sarbanes- Oxley Act of 2002                                                    
|     |                                                                                                                                                               
|32.1 | Certification of Chief Executive Officer pursuant
      to 18 U.S.C. section 1350,as adopted pursuant to section 906 of
      the Sarbanes-Oxley act of 2002. 
|     |                                                                                                                                                               
|32.2 | Certification of Chief Accounting Officer pursuant
      to U. S. C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley
      act of 2002.

There were no reports filed on Form 8-K during the three month period ended
  November 30, 2003.

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Crown Medical Systems, Inc.

/s/ William Sklar
  William Skjlar, Director

Date: January 14, 2004.

---